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Abstract - The following report describes a patient who begun cocaine use as a self-treatment for 
migraine headaches and developed a full-blown cocaine dependency disorder. Treatment implica- 
tions are discussed in relation to the self-medication hypothesis of addictive disorders. The discus- 
sion concludes that both initiating and perpetuating factors in substance abuse must be addressed 
for effective treatment to occur. 
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INTRODUCTION 
COCAINE I; A COMMONLY ABUSED drug with a high 
potential for adverse consequences (Smith, 1984). 
Although the etiology of cocaine dependence is com- 
plex, the self-medication hypothesis asserts that cer- 
tain persons initiate cocaine use in order to medicate 
themselves for an underlying psychiatric disorder 
(Khantzian, 1985). This hypothesis is supported in 
part by diagnostic studies which suggest a high preva- 
lence of psychopathology in cocaine abusers (Gawin 
& Kleber, 1986; Weiss, Mirin, Michael, & Sollogub, 
1986). 
Additional support is provided by a number of 
case reports which describe patients who apparently 
used cocaine to self-medicate either affective disorders 
(Gawin & Kleber, 1984; Weiss & Mirin, 1986) or at- 
tention deficit disorder (Khantzian, 1983; Khantzian, 
Gawin, Kleber, & Riordan, 1984; Weiss, Pope, & 
Mirin, 1985). In most of these case reports, specific 
pharmacotherapy for the psychiatric disorder resulted 
in dramatic improvement in the cocaine dependence. 
An unfortunate, albeit presumably unintentional, im- 
pression left by some of these reports is that optimal 
pharmacotherapy for the underlying psychiatric disor- 
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der provides sufficient treatment for the cocaine de- 
pendence. Alternatively, Weiss and Mirin (1986) state 
that pharmacotherapy for coexisting disorders should 
occur within the context of a comprehensive treatment 
program for substance dependence. 
The following report emphasizes this important 
point by describing a patient who used cocaine to self- 
medicate migraine headaches. Although migraine 
headaches are not strictly classified as a mental disor- 
der, the case is analogous to the reports cited above in 
terms of the self-medication motive. Thus, treatment 
implications are discussed in relation to the self- 
medication hypothesis of addictive disorders. 
CASE REPORT 
The patient was a 29 year old man who began having 
headaches at age 23. The headache was described as 
a throbbing pain over the right temple that lasted 
between four hours and four days. Headaches were 
preceded by blurred vision, flashing purple and clear 
lights, and were associated with nausea. They oc- 
curred between one and four times per month. Dur- 
ing a headache, the patient preferred to lie still in a 
dark, quiet room until it subsided. If he took a com- 
bination of ergotamine and caffeine early in the 
course of a headache, he sometimes obtained relief. 
He avoided taking more than two pills during an epi- 
sode and so used the medication suboptimally. Previ- 
ous trials with propanolol and amitriptyline were 
unsuccessful in treating his migraines. 
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He first tried smoking freebase cocaine at age 27 at 
the urging of a friend who suggested that it might 
help a headache he had at the time. Indeed, he 
noticed immediate and complete relief lasting between 
five and fifteen minutes, after which the euphoric 
peak subsided and his headache returned. He found 
that he could sustain relief with each additional “hit 
off the pipe” for another five to fifteen minutes, after 
which the headache returned again. Eventually, he 
depleted the supply of cocaine, “crashed,” and fell 
asleep. When he awoke, the headache was gone. He 
repeated this pattern for the next three headaches he 
had. After his fourth episode of smoking cocaine, he 
began to use cocaine even when he did not have a 
headache. The cocaine never brought on a migraine 
headache if he did not already have one at the begin- 
ning of use. 
Gradually, his use of cocaine escalated until he was 
consuming between 10 to 14 grams every two weeks at 
a cost of $1000. Typically, he experienced little or no 
craving between paydays; but as soon as he had his 
paycheck in hand, he felt an intense desire to obtain 
and use cocaine. Within the, one month prior to 
admission, the patient lost his job and marriage due 
to cocaine use. Having exhausted all social and finan- 
cial resources, the patient lived on the streets before 
finally seeking treatment. 
The patient did not meet DSM-III-R criteria for 
abuse of or dependence on any other substances 
(American Psychiatric Association, 1987), although 
there was a history of alcohol and marijuana use prior 
to the initiation of cocaine use. 
The patient was treated on a specialized inpatient 
ward for substance abuse. The treatment consisted of 
individual and group therapy that was supplemented 
by drug education. An ergotamine preparation was 
prescribed for the headaches, and instructions were 
given for optimal use. During the 28 days of inpatient 
treatment, the patient remained free of cocaine and 
experienced only one headache, which was mild and 
responded to four hours of bedrest. Following the 
inpatient program, he was discharged to a half-way 
house for recovering substance abusers. 
DISCUSSION 
This may be the first reported case to describe the 
development of cocaine dependence in a migraine 
patient. Although abuse and dependence with opioids 
and barbiturates are well-documented among patients 
with migraine and other chronic headaches (Lange- 
mark & Olesen, 1984; Medina & Diamond, 1977), 
cocaine dependence among these patients is not. More 
importantly, the case illustrates cocaine use which 
apparently began as a self-treatment for headaches 
and culminated in a full-blown cocaine dependence. 
When planning the treatment strategy for the patient, 
it was helpful to consider both the factors that initiated 
cocaine use and the factors that perpetuated addictive 
use. Therefore, the following discussion will focus on 
both of these groups of factors and their implications 
for treatment. 
The research regarding risk factors for the initiation 
of cocaine use has recently been reviewed (Brower & 
Anglin, 1987). The major risk factors appear to be 
male gender, prior use of “gateway” drugs such as 
marijuana, lack of social connections to family and 
nonusing peers, other peer influences, and psychopa- 
thology. Physical disorders, as exemplified in this 
case, have not been systematically studied as potential 
risk factors for initiating cocaine use. Historically, 
however, cocaine was once considered a panacea for 
a variety of common ailments such as headaches, the 
common cold, sore throats, back pain, muscle stiff- 
ness, nervous stomach disorders, and asthma (Grin- 
spoon & Bakalar, 1985). The legal availability and 
marketing of cocaine in a variety of over-the-counter 
patent medicines prior to 1914 made the initiation of 
cocaine use by Americans to self-medicate these ail- 
ments inevitable and common. 
Although an argument is made that self-medication 
of headaches was the major factor that initiated this 
patient’s use of cocaine, other risk factors cited above 
such as male gender, prior use of marijuana, and peer 
influences were present and operative. It is also pos- 
sible that the migraine headaches were primarily used 
by the patient as a rationalization for his initial cocaine 
use. Likewise, other cocaine addicts, such as the 
depressed patient described by Weiss and Mirin (1986), 
may use depression as a rationalization for use. Cli- 
nicians need to be careful not to collude with possible 
rationalizations for cocaine use by neglecting to treat 
cocaine dependence when present. 
An examination of the phenomenology of cocaine 
dependence suggests that the factors involved in per- 
petuating addictive use may be quite distinct from 
those involved in initiating use. The lives of patients 
dependent on cocaine become increasingly organized 
around thinking about, obtaining, using, and recover- 
ing from the effects of the drug. Their relationship 
with the chemical eventually supersedes prior relation- 
ships with other people and activities. In this patient, 
for example, compulsive use continued despite adverse 
consequences such as marital, job, and financial 
losses. Initially, however, when self-medication was 
his motive, he was able to terminate his cocaine use 
when the migraine symptoms subsided. Other patients 
who are purely self-medicating their psychiatric symp- 
toms should manifest a similar pattern of controlled 
use. By contrast, his addictive use was related to new 
symptoms, such as craving, which occurred in the 
absence of migraines. 
Dependent cocaine users often report profound 
euphoria with immediate use alternating with equally 
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profound dysphoria, craving, and other withdrawal 
symptoms when the acute effects subside (Gawin & 
Kleber, 1986). Self-medication of these withdrawal 
symptoms along with attempts to reexperience the ini- 
tial euphoria can contribute to compulsive use and a 
cycle of addiction, regardless of the reasons for initial 
use. While an increase in the cerebral neurotransmit- 
ter dopamine is thought to mediate cocaine’s reinforc- 
ing and euphoric effects (Wise, 1984), dopaminergic 
hypofunctioning may underlie the craving and with- 
drawal symptoms (Dackis & Gold, 198Sa, 1985b). By 
this conceptualization, the user may be driven to use 
more cocaine in order to restore dysfunctional dopa- 
mine systems. 
Further evidence that the risk factors for initial and 
addictive cocaine use are distinct is provided by lon- 
gitudinal studies of cocaine users. These studies indi- 
cate that not all users of cocaine progress to more 
frequent or compulsive use (O’Malley, Johnston, & 
Bachman, 1985; Siegel, 1984). Although the risk fac- 
tors for addictive cocaine use are not well studied, 
genetic factors (Cadoret, Troughton, O’Gorman, & 
Heywood, 1986), psychiatric vulnerability (Gawin, 
1986), rapid routes of administration such as smoking 
(Siegel, 1984), and an early age at initial drug use 
(Robins & Przybeck, 1985) are likely to be important. 
A theoretical possibility is that some users are biolog- 
ically more prone to develop dopamine dysfunction 
with initial uses and, thus, they proceed to develop an 
addiction to cocaine. 
Treatment in this case consisted of specific phar- 
macotherapy for the migraines and a conventional, 
inpatient chemical dependency program with aftercare 
placement for the cocaine dependence. Specific phar- 
macotherapy consisted of an ergotamine preparation. 
Ergotamine, which is believed to exert its therapeutic 
effect via vasoconstriction, is the pharmacological 
treatment of choice for acute migraine (Lance, 1986). 
Similarly, cocaine is a potent vasoconstrictor (Ritchie 
& Greene, 1980), and this may have explained its self- 
medicating effect in this case. Antidepressants have 
been used both to prevent migraine headaches (Lance, 
1986) and to treat cocaine dependence, even in the 
absence of coexisting depression (Gawin and Kleber, 
1984; Rosecan & Nunes, 1987). A previous trial of 
amitriptyline in this patient was ineffective in prevent- 
ing his headaches, However, antidepressants might 
represent optimal pharmacotherapy for other patients 
who suffer with both disorders. 
The 28 day period of observation in the protected 
milieu of a hospital limits the conclusions that can be 
made about the longterm efficacy of the chosen treat- 
ment regimen. Nevertheless, the case illustrates an 
important treatment principle when chemically-de- 
pendent patients present with coexisting disorders and 
self-medication as a motive. An impression given by 
other reports which illustrate the self-medication mo- 
tive is that appropriate clinical treatment of the “pri- 
mary” disorder, which initiates a patient into abusing 
cocaine, will result in remission of the cocaine depen- 
dence (Khantzian, 1983; Khantzian et al., 1984). In 
this case, however, migraine therapy in the form of 
ergotamine would not have been sufficient treatment 
for the cocaine dependence, because this patient abused 
cocaine even when his headaches were absent. 
When applying the self-medication hypothesis to 
treatment strategy, it is important to distinguish be- 
tween initiating and perpetuating factors in substance 
dependence. Although the self-treatment of headaches 
was a major factor involved in the initiation of this 
patient’s cocaine use, it was not a particularly impor- 
tant factor in the perpetuation of his compulsive use. 
As the patient stated, “I knew after four times [of 
using cocaine to treat my headaches] that I was ad- 
dicted, because then I began buying cocaine even 
when I didn’t have a headache.” Perpetuating factors 
in this patient’s abuse included the powerful, bio- 
logically-reinforcing properties of cocaine (Wise, 
1984), which were enhanced by the smoking route, 
and the conditioned cues for craving (Dackis & Gold, 
1985b; Gawin & Kleber, 1986), such as receiving his 
paycheck. It is obvious that migraine therapy would 
not have addressed these perpetuating factors. 
In conclusion, the risk factors associated with ini- 
tial cocaine use and the perpetuating factors that 
underlie cocaine dependence may be quite distinct. A 
corollary for treatment is that both initiating and per- 
petuating factors must be addressed for effective 
treatment to occur. Patients who start using cocaine 
or other substances in order to self-medicate their 
depression, attention deficit disorder, migraines, etc. 
may develop a substance use disorder that requires its 
own treatment. Treating substance abuse as secondary 
to, or as a mere symptom of, an initiating disorder is 
usually insufficient. This is especially true when pow- 
erful, perpetuating factors develop in addition to a 
pharmacologically-responsive, initiating disorder. 
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